{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumococcal+13-valent+Conjugate+Vaccine", "query": { "intervention": "Pneumococcal 13-valent Conjugate Vaccine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 94, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumococcal+13-valent+Conjugate+Vaccine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T00:56:49.334Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03547167", "title": "A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "V114", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "PNEUMOVAX™23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 1515, "start_date": "2018-07-16", "completion_date": "2020-01-20", "has_results": true, "last_update_posted_date": "2021-01-15", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 38, "location_summary": "Chinle, Arizona • Fort Defiance, Arizona • Glendale, Arizona + 34 more", "locations": [ { "city": "Chinle", "state": "Arizona" }, { "city": "Fort Defiance", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Whiteriver", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03547167" }, { "nct_id": "NCT03803202", "title": "A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pneumonia, Bacterial", "Healthy Volunteers", "Pneumococcal Disease" ], "interventions": [ { "name": "ASP3772", "type": "BIOLOGICAL" }, { "name": "PCV13", "type": "BIOLOGICAL" }, { "name": "PPSV23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 630, "start_date": "2019-01-24", "completion_date": "2020-09-28", "has_results": true, "last_update_posted_date": "2023-12-21", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 26, "location_summary": "Banning, California • San Diego, California • San Marcos, California + 21 more", "locations": [ { "city": "Banning", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Marcos", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Savannah", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03803202" }, { "nct_id": "NCT03165981", "title": "Fever After Simultaneous Versus Sequential Vaccination in Young Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fever After Vaccination", "Fever", "Febrile Seizure" ], "interventions": [ { "name": "PCV13", "type": "BIOLOGICAL" }, { "name": "DTaP", "type": "BIOLOGICAL" }, { "name": "IIV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "16 Months", "sex": "ALL", "summary": "12 Months to 16 Months" }, "enrollment_count": 221, "start_date": "2017-08-25", "completion_date": "2018-01-15", "has_results": true, "last_update_posted_date": "2024-11-18", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 3, "location_summary": "Oakland, California • Atlanta, Georgia • Durham, North Carolina", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03165981" }, { "nct_id": "NCT00474526", "title": "A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis, Meningococcal" ], "interventions": [ { "name": "Meningococcal ACWY Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV-HBV", "type": "BIOLOGICAL" }, { "name": "Hib", "type": "BIOLOGICAL" }, { "name": "Rotavirus", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 7-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "HAV", "type": "BIOLOGICAL" }, { "name": "MMR-V", "type": "BIOLOGICAL" }, { "name": "DTaP", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Months", "maximum_age": "2 Months", "sex": "ALL", "summary": "2 Months to 2 Months" }, "enrollment_count": 4545, "start_date": "2007-03", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2014-03-24", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 53, "location_summary": "Bessemer, Alabama • Birmingham, Alabama • Downey, California + 43 more", "locations": [ { "city": "Bessemer", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Downey", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00474526" }, { "nct_id": "NCT03942328", "title": "Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stage III Hepatocellular Carcinoma AJCC v8", "Stage III Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IV Hepatocellular Carcinoma AJCC v8", "Stage IV Intrahepatic Cholangiocarcinoma AJCC v8", "Unresectable Hepatocellular Carcinoma", "Unresectable Intrahepatic Cholangiocarcinoma" ], "interventions": [ { "name": "Atezolizumab", "type": "BIOLOGICAL" }, { "name": "Bevacizumab", "type": "BIOLOGICAL" }, { "name": "External Beam Radiation Therapy", "type": "RADIATION" }, { "name": "Pheresis", "type": "PROCEDURE" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Therapeutic Autologous Dendritic Cells", "type": "BIOLOGICAL" }, { "name": "Durvalumab", "type": "BIOLOGICAL" }, { "name": "Esophagogastroduodenoscopy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "RADIATION", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 85, "start_date": "2019-09-19", "completion_date": "2031-02-28", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03942328" }, { "nct_id": "NCT03207750", "title": "This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rotavirus Infection", "Rotavirus Vaccines" ], "interventions": [ { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevenar 13", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1280, "start_date": "2017-09-14", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Daly City", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207750" }, { "nct_id": "NCT01083459", "title": "Impact of PCV on Disease and Colonization Among Native American Communities", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pneumococcal Nasopharyngeal Colonization", "Invasive Pneumococcal Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Months", "maximum_age": null, "sex": "ALL", "summary": "7 Months and older" }, "enrollment_count": 6628, "start_date": "2010-01", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2015-01-19", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 2, "location_summary": "Whiteriver, Arizona • Gallup, New Mexico", "locations": [ { "city": "Whiteriver", "state": "Arizona" }, { "city": "Gallup", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01083459" }, { "nct_id": "NCT00980655", "title": "Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vaccines, Pneumococcal Conjugate Vaccine" ], "interventions": [ { "name": "13vPnC", "type": "BIOLOGICAL" }, { "name": "23vPS", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 251, "start_date": "2010-01-18", "completion_date": "2013-05-16", "has_results": true, "last_update_posted_date": "2018-12-20", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 9, "location_summary": "Lexington, Kentucky • New Hyde Park, New York • New York, New York + 2 more", "locations": [ { "city": "Lexington", "state": "Kentucky" }, { "city": "New Hyde Park", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00980655" }, { "nct_id": "NCT03950856", "title": "Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections", "Pneumonia, Pneumococcal" ], "interventions": [ { "name": "V114", "type": "DRUG" }, { "name": "Prevnar 13™", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 2340, "start_date": "2019-06-12", "completion_date": "2020-04-03", "has_results": true, "last_update_posted_date": "2021-04-12", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 30, "location_summary": "Chandler, Arizona • Mesa, Arizona • Fountain Valley, California + 26 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03950856" }, { "nct_id": "NCT03537508", "title": "Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy Volunteers (Meningococcal Infection)" ], "interventions": [ { "name": "MenACYW conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "MenACYW-135 conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV//Hib vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Pentavalent rotavirus vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, rubella (MMR) vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2627, "start_date": "2018-04-25", "completion_date": "2023-09-22", "has_results": true, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-29T00:56:49.334Z", "location_count": 65, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03537508" } ] }